ERBB2 and breast cancer: This can most likely be explained by the fact that none of the Wilkerson subtypes have (yet) been associated with a driver event, unlike breast cancer where ESR1 and ERBB2 have been identified as strong drivers giving rise to specific subtypes of breast cancer.